老虎證券

BUZZ-ADMA Biologics shares hit record high after FDA approves plasma yield process

Reuters
04-28
BUZZ-ADMA Biologics shares hit record high after FDA approves plasma yield process

** Shares of ADMA Biologics ADMA.O hit a record high on Mon after the biopharmaceutical company won FDA approval for its plasma yield enhancement production process

** ADMA rose to as high as $25.67, highest level on record, and on track for the highest daily pct gain since Nov last year

** ADMA's process demonstrated an ability to increase production yields by approximately 20% from the same starting plasma volume

** "This approval represents a pivotal milestone for ADMA, unlocking the opportunity for meaningful acceleration in our revenue and earnings trajectory beginning in late 2025 and accelerating further into 2026 and beyond," said ADMA CEO Adam Grossman in a statement

** Among the 4 analysts that cover ADMA, the breakdown of recommendations are 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell"

** ADMA is up 45% YTD versus 0.53% gain in the S&P 500 health index .SPXHC

(Reporting by Chibuike Oguh in New York)

((Chibuike.Oguh@thomsonreuters.com; +332-219-1834; Reuters Messaging: chibuike.oguh.thomsonreuters.com@reuters.net))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10